Predictive factors for generalized seizures after deliberate citalopram overdose

British Journal of Clinical Pharmacology

Volumn 66, Issue 6, 2008, Pages 861-865

  Waring, W Stephen ^a   Gray, Julie A ^a   Graham, Ann ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Adverse effects; Dose response; Drug toxicity; Poisoning

Indexed keywords

ACTIVATED CARBON; ALCOHOL; BENZODIAZEPINE; CITALOPRAM; CREATINE KINASE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROLYTE DISTURBANCE; ENZYME ACTIVITY; FEMALE; GRAND MAL SEIZURE; HIGH RISK POPULATION; HUMAN; HYPONATREMIA; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CITALOPRAM; CYCLOHEXANOLS; DRUG INTERACTIONS; EMERGENCY MEDICINE; FEMALE; HUMANS; MALE; OVERDOSE; PROGNOSIS; RETROSPECTIVE STUDIES; SEIZURES; SELF-INJURIOUS BEHAVIOR; YOUNG ADULT;

EID: 56549110759     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03294.x     Document Type: Article

References (27)

1. Milne RJ, Goa KL. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 1991 41 : 450 77.
2. Bertilsson L, Dahl M-L. Polymorphic drug oxidation. Relevance to the treatment of psychiatric disorders. CNS Drugs 1996 3 : 200 23.
3. Murdoch D, Keam SJ. Escitalopram: a review of its use in the management of major depressive disorder. Drugs 2005 65 : 2379 404.
4. Nemeroff CB. Overview of the safety of citalopram. Psychopharmacol Bull 2003 37 : 96 121.
5. Seethalakshmi R, Krishnamoorthy ES. Depression in epilepsy: phenomenology, diagnosis and management. Epileptic Disord 2007 9 : 1 10.
6. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004 42 : 277 85.
7. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004 42 : 67 71.
8. Masullo LN, Miller MA, Baker SD, Bose S, Levsky M. Clinical course and toxicokinetic data following isolated citalopram overdose in an infant. Clin Toxicol 2006 44 : 165 8.
9. Engebretsen KM, Harris CR, Wood JE. Cardiotoxicity and late onset seizures with citalopram overdose. J Emerg Med 2003 25 : 163 6.
10. Cuenca PJ, Holt KR, Hoefle JD. Seizure secondary to citalopram overdose. J Emerg Med 2004 26 : 177 81.
11. Kabuto H, Yokoi I, Takei M, Kurimoto T, Mori A. The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain. Neurochem Res 1994 19 : 463 7.
12. Favale E, Audenino D, Cocito L, Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003 12 : 316 8.
13. Wilson AD, Howell C, Waring WS. Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series. J Toxicol Sci 2007 32 : 97 101.
14. Covyeou JA, Jackson CW. Hyponatremia associated with escitalopram. N Engl J Med 2007 356 : 94 5.
15. Odeh M, Beny A, Oliven A. Severe symptomatic hyponatremia during citalopram therapy. Am J Med Sci 2001 321 : 159 60.
16. Fisher A, Davis M, Croft-Baker J, Purcell P, McLean A. Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev 2002 21 : 179 87.
17. Wilhelm K, Curtis J, Birkett V, Kenney-Herbert J. The clinical significance of serial creatine phosphokinase estimations in acute ward admissions. Aust N Z J Psychiatry 1994 28 : 453 7.
18. Spigset O, Hedenmalm K, Dahl ML, Wiholm BE, Dahlqvist R. Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors. Acta Psychiatr Scand 1997 96 : 379 84.
19. Personne M, Sjöberg G, Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997 35 : 237 40.
20. Grundemar L, Wohlfart B, Lagerstedt C, Bengtsson F, Eklundh G. Symptoms and signs of severe citalopram overdose. Lancet 1997 349 : 1602.
21. Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, de Tommaso M, Pizzanelli C, Murri L. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004 27 : 133 6.
22. Morita K, Hamamoto M, Arai S, Kitayama S, Irifune M, Kawahara M, Kihira K, Dohi T. Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities. Brain Res 2005 1057 : 153 60.
23. Boeck V, Fredricson Overø K, Svendsen O. Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol (Copenh) 1982 50 : 169 74.
24. Isbister GK, Friberg LE, Stokes B, Buckley NA, Lee C, Gunja N, Brown SG, MacDonald E, Graudins A, Holdgate A, Duffull SB. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007 50 : 593 600.
25. Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: a case series. Ann Emerg Med 2003 42 : 751 8.
26. Waring WS, Robinson ODG, Stephen AFL, Dow MA, Pettie JM. Does the patient history predict hepatotoxicity after acute paracetamol overdose. Q J Med 2008 101 : 121 5.
27. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 2003 96 : 369 74.